113 studies on Apoptosis mechanism curated from PubMed, ClinicalTrials.gov, and EuropePMC. Updated daily.
Sepsis-associated encephalopathy (SAE) represents a critical unmet medical need, with current treatments offering limited efficacy against its severe cognitive sequelae. This research provides compelling evidence that…
This research highlights Elamipretide's significant potential as an additive to cryopreservation solutions, offering a novel strategy to mitigate cellular damage during ovarian tissue vitrification. By protecting mito…
This research highlights a novel strategy for overcoming acquired drug resistance in lung cancer, a major clinical challenge. By targeting the ghrelin receptor, this study demonstrates a potential pathway to re-sensit…
This research highlights Acylated Ghrelin as a promising therapeutic agent to prevent or reduce doxorubicin-induced cardiotoxicity. By targeting the Fas/FasL apoptotic pathway and enhancing SERCA2a activity, it offers…
These findings are highly significant as they demonstrate that Ghrelin acts as a potent neuroprotective agent against HIE-induced brain injury by modulating oxidative stress and neuronal apoptosis. The elucidation of …
This research highlights acylated ghrelin's potential as a potent renoprotective agent against chemotherapy-induced kidney damage. By activating SIRT1, a protein involved in cellular health and longevity, ghrelin appe…
This study provides compelling evidence that Ghrelin can protect intestinal epithelial cells from apoptosis in Ulcerative Colitis by activating the Unfolded Protein Response (UPR) pathway. This identifies a novel ther…
This research highlights the critical importance of ghrelin balance for successful embryo implantation and pregnancy outcomes, extending its known roles beyond metabolism. Understanding how ghrelin misbalance disrupts…
This research highlights GHRP-6 as a promising therapeutic agent to protect against the severe organ damage caused by doxorubicin chemotherapy. By activating intrinsic prosurvival mechanisms, GHRP-6 could potentially …
This research highlights ghrelin as a potential therapeutic agent for combating pancreatic β-cell dysfunction and apoptosis, which are central to the progression of type 2 diabetes. By targeting ER stress and the IRE1…
This research highlights Danshen-Chuanxiong-Honghua (DCH) as a promising multi-target therapeutic agent for traumatic brain injury, offering both anti-inflammatory and neuroprotective benefits. The specific identifica…
These findings are highly significant as they identify the GHRH receptor as a novel and promising therapeutic target for triple-negative breast cancer, a disease with limited treatment options. The potent anti-prolife…
This research elucidates a critical molecular pathway by which GHRH antagonists like JMR-132 exert their anti-cancer effects, specifically highlighting the essential role of p21/waf1 (a protein that halts cell divisio…
This study highlights a novel therapeutic approach for breast cancer treatment by targeting the GHRH pathway, showing efficacy across both ER+ and ER- subtypes. The ability of MZ-4-71 to inhibit the growth of ER- brea…
These findings are significant as they identify GHRH as a trophic hormone for bronchial neuroendocrine tumors, meaning it actively promotes their growth and activity. This discovery suggests that GHRH receptors could …
This study provides compelling evidence that GHRH antagonists possess significant antiproliferative and pro-apoptotic effects on ovarian cancer cells by targeting the EGFR-Akt signaling pathway. This discovery highlig…
This research highlights the therapeutic potential of GHRH antagonists as a novel and targeted approach for treating prostate cancer. By modulating key cellular pathways, specifically restoring the function of the p53…
Given the aggressive nature and poor prognosis of advanced ovarian cancer, identifying new therapeutic avenues is paramount. This research highlights GHRH antagonists as a highly promising novel therapeutic strategy f…
These findings strongly suggest that GHRH antagonists could be a potent new therapeutic strategy for advanced prostate cancer by simultaneously inhibiting tumor growth and its ability to spread. The observed reduction…
This research highlights a promising new therapeutic strategy for triple-negative breast cancer, a disease with limited treatment options and a high unmet medical need. The synergistic effects observed with GHRH antag…
This research provides compelling evidence that activating GHRH signaling can effectively counteract the neurodegenerative processes triggered by intermittent hypoxia. This suggests that GHRH agonists could represent …
This study highlights the therapeutic potential of GHRH antagonists as a novel and targeted strategy for treating malignant melanoma, a cancer with high unmet medical needs. By demonstrating that these compounds resto…
This research highlights a novel therapeutic strategy for heart failure post-MI by targeting the GHRH receptor, which is often overexpressed in damaged hearts and contributes to pathological remodeling. The significan…
This research highlights GHRH analogs as a promising new class of therapeutic agents for enhancing wound healing. By directly stimulating the proliferation and survival of human dermal fibroblasts, these compounds cou…
This research highlights the significant potential of GHRH receptor antagonists as a novel and targeted therapeutic strategy for gastric cancer. By demonstrating their ability to inhibit tumor growth and induce apopto…
These findings highlight GHRH receptor antagonists as a promising therapeutic strategy for prostate cancer by targeting multiple pathways involved in tumor growth and angiogenesis. The ability to inhibit both cell pro…
This study highlights MR-409 as a promising therapeutic candidate for preventing beta-cell destruction, a critical step in managing Type 1 Diabetes and potentially other forms of diabetes where beta-cell loss is a fac…
This research highlights a promising new strategy to overcome radioresistance in NSCLC, a major challenge in oncology. By targeting the GHRH pathway, MIA-602 appears to sensitize cancer cells to radiation, potentially…
This research highlights the potential of a dermofunctional vehicle to therapeutically intervene in skin conditions characterized by inflammation, excessive tissue breakdown, or impaired healing. By downregulating LL-…
These findings fundamentally advance our understanding of how antimicrobial peptides interact, highlighting that peptide aggregation is a critical determinant of AMP structure-function relationships. This mechanistic …
This review critically highlights the therapeutic potential of GHRPs beyond their established GH-releasing properties, suggesting they could be novel pharmacological agents for treating various cardiovascular diseases…
This study provides compelling evidence that Epitalon can effectively inhibit colon carcinogenesis by modulating key cellular processes: reducing cell proliferation (growth) and enhancing apoptosis (cell death) within…
This research provides crucial insights into the molecular mechanisms underlying the biological effects of melatonin and Epithalon, particularly their impact on brain gene regulation. By identifying specific genes inv…
This research highlights the neuroprotective and regenerative potential of pineal peptides, specifically Epitalon and Epithalamin, in combating age-related decline in brain cell proliferation. The ability of these pep…
This research uncovers novel mechanisms by which short regulatory peptides exert their protective effects, moving beyond simple direct antioxidant activity. The findings suggest these peptides could play a crucial rol…
These findings are significant as they identify specific short peptides, particularly Ala-Glu-Asp-Gly, that can tissue-specifically stimulate both the growth and secretory functions of pinealocytes. This suggests a pr…
These results are highly significant as they suggest that these specific peptides could serve as novel therapeutic agents for combating skin aging and potentially other age-related conditions. Their ability to modulat…
This research provides compelling evidence that Epitalon can effectively delay the aging process of oocytes in vitro by modulating crucial cellular pathways, specifically by reducing ROS levels and enhancing mitochond…
This study provides compelling evidence that Semax possesses significant neuroprotective and cognitive-enhancing properties in a preclinical model of ischemic stroke. The observed reduction in infarct volume and impro…
This novel iPSC-based platform offers a powerful, human-relevant tool for accelerating neuroprotective drug discovery, potentially reducing the reliance on less predictive animal models and improving the translatabili…
This study provides compelling evidence that MIF and Selank possess significant neuroprotective and anti-inflammatory properties in the context of hemorrhagic stroke. The observed improvements in neurological function…
Understanding the evolutionary history and selective pressures on humanin and SHLP6 provides crucial insights into their functional significance and potential roles in health and disease. The identification of sites u…
This research strongly positions mitochondrial-derived peptides as a novel and potent class of therapeutic agents for the management of Type 2 Diabetes. Their ability to simultaneously improve insulin sensitivity, red…
This research highlights MOTS-c as a novel and potent regulator of NASH progression, acting through a direct interaction with Bcl-2 to mitigate hepatic steatosis, inflammation, and fibrosis. The findings underscore th…
This research is significant as it identifies Humanin and MOTS-c as potential protective agents against chemotherapy-induced reproductive damage. Given the devastating impact of male infertility on cancer survivors, f…
This research highlights MOTS-c's potential as a novel therapeutic agent to enhance the efficacy of existing cancer treatments by overcoming drug resistance, particularly in challenging tumor microenvironments like hy…
This research highlights MOTS-c as a promising novel therapeutic agent for allergic asthma, offering a unique approach by targeting a fundamental aspect of the disease: airway barrier dysfunction and epithelial apopto…
This research highlights the significant potential of MOTS-c-modified peptide hydrogels as a novel therapeutic strategy for intervertebral disc degeneration. By enhancing the activity and survival of NP-MSCs, this app…